TP53 and Ewing sarcoma: In a different example, a somatic TP53 nonsense mutation with a high VAF = 0.608, was reported in the plasma of a stage IV Ewing sarcoma patient (ESR-pt01, 199x coverage; Table S1) after leveraging the XGen© Pan-Cancer Panel.